Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. QALSODY (tofersen)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

QALSODY (tofersen)

Medicine - Posted on Nov 28 2024
Active substance (DCI)
  • tofersen
history (2)
  • 11/20/24

    QALSODY (tofersen) - Amyotrophic lateral sclerosis (ALS)

    Summary of opinion Unfavourable opinion for reimbursement in the treatment of adults with amyotrophic lateral sclerosis (ALS...
    CAV :
    54321
    icône flèche
  • 10/10/24

    QALSODY (tofersen) - Sclérose latérale amyotrophique

    Autorisation d’accès précoce refusée à la spécialité QALSODY (tofersen) dans l’indication « traitement des adultes atteints ...
    icône flèche
Technical information
ATC code
  • N07XX22
Manufacturer
BIOGEN FRANCE SAS
Presentation

QALSODY 100 mg, solution injectable
1 flacon en verre de 15 ml (CIP : 34009 551 010 3 1)

See also

MISE AU POINT
08/11/2024
Qalsody : mise au point de la HAS
All our publications
    Congenital, genetic and rare diseases Drug therapy Neurodegenerative diseases Neuromuscular diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
QNywdLwZShSmwsFz